Trials
Search / Trial NCT05648565

Effects of Radiofrequency Ablation of Posterior Nasal Nerves on Inflammatory Cytokines, Peak Nasal Inspiratory Flow, and Nasal Blood Flow in Patients With Chronic Rhinitis

Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Dec 5, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Completed

Keywords

Radiofrequency Ablation

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • chronic rhinitis symptoms for at least 6 months (rhinorrhea, congestion, post-nasal drip)
  • • poor response to medical management that was attempted for at least 4 weeks
  • • a rTNSS score ≥6, as well as ≥2 for rhinorrhea, and ≥1 for congestion.
  • Exclusion Criteria:
  • • active sinusitis
  • • rhinitis medicamentosa
  • • recurrent and ongoing epistaxis
  • • immunodeficiency as defined by an illness or a history of sinus surgery.

Trial Officials

David Z Allen, MD

Principal Investigator

The University of Texas Health Science Center, Houston

About The University Of Texas Health Science Center, Houston

The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.

Locations

Houston, Texas, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials